XTalks

DECEMBER 4, 2024

Jotrol overcomes these barriers using patented micellar technology, enhancing bioavailability and enabling therapeutically effective doses. CAMP4’s RNA-based therapies focus on genetic diseases like urea cycle disorders, while Rapport’s small molecules aim to address epilepsy, pain and bipolar disorder.

Bioavailability 111

Bioavailability Genetic Disease Marketing RNA 111

XTalks

JUNE 14, 2023

Furthermore, the bioavailability of the active pharmaceutical ingredient (API) into the cornea is up to four times stronger with EyeSol technology. In addition, Sylentis, a biotech company specializing in ophthalmic drugs and RNA interference (RNAi) technology, initiated a Phase III study in 2021.

Gene Silencing 97

Gene Silencing Drug Delivery FDA Approval RNA 97

XTalks

AUGUST 30, 2022

A major obstacle for CNS drug developers is the inability to target therapies to the CNS broadly (for instance, a therapy that is orally bioavailable as a pill and has difficulty crossing the blood-brain barrier) and certain CNS regions more specifically. The patients are waiting! Modern-Day Applications of Direct CNS Administration.

Trials 83

Trials Drug Delivery Drugs Gene 83

Roots Analysis

JANUARY 28, 2024

She holds a bachelor’s degree in pharmaceutical sciences from a prestigious institute, which has provided her with a strong academic background. With her commitment to staying at the forefront of the healthcare and life sciences domain, she is able to effectively analyze complex datasets and provide actionable insights.

Big Data 40

Big Data Medicine Marketing Clinical Trials 40